Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3-Reference-Cited by-同舟云学术

Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3

Published:2014-09-19 Issue:9 Volume:9 Page:e107592
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Niederau Claus,Mauss Stefan,Schober Andreas,Stoehr Albrecht,Zimmermann Tim,Waizmann Michael,Moog Gero,Pape Stefan,Weber Bernd,Isernhagen Konrad,Sandow Petra,Bokemeyer Bernd,Alshuth Ulrich,Steffens Hermann,Hüppe Dietrich

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference51 articles.

1. Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection;C Sarrazin;Z Gastroenterol,2010

2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;J Hepatol,2011

3. Diagnosis, management, and treatment of hepatitis C: an update;MG Ghany;Hepatology,2009

4. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;SJ Hadziyannis;Ann Intern Med,2004

5. Treatment with pegylated interferon and ribavirin in HCV infection with genotype 2 or 3 for 14 weeks: a pilot study;O Dalgard;Hepatology,2004

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world effectiveness and safety of direct-acting antivirals in hepatitis C virus patients with mental disorders;World Journal of Gastroenterology;2023-07-07

2. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología;2023-05

3. Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: Results of a literature review;Gastroenterología y Hepatología (English Edition);2023-05

4. Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders;BMC Infectious Diseases;2020-03-06

5. Direct-acting antiviral treatment in real world patients with hepatitis C not associated with psychiatric side effects: a prospective observational study;BMC Psychiatry;2018-05-29